Significant decrease of the International Index of Erectile Function in male renal failure patients treated with

Y Naya1, J Soh, A Ochiai

  • 1Department of Urology, Kyoto Prefectural University of Medicine, Kyoto, Japan.

Insights

Erectile dysfunction (ED) is significantly more common and severe in men undergoing hemodialysis (HD) compared to healthy individuals. Diabetes and age are key risk factors for sexual dysfunction in these patients.

Area of Science:

  • Nephrology
  • Urology
  • Andrology

Background:

  • Chronic kidney disease and hemodialysis (HD) significantly impact male health.
  • Erectile dysfunction (ED) is a common comorbidity in patients with renal failure.
  • Understanding ED prevalence and risk factors in HD patients is crucial for patient care.

Purpose of the Study:

  • To evaluate erectile function in male patients undergoing hemodialysis.
  • To compare the prevalence and severity of ED in HD patients versus healthy controls.
  • To identify risk factors for ED in HD patients.

Main Methods:

  • Utilized the International Index of Erectile Function (IIEF) to assess erectile function.
  • Compared 174 male HD patients (including 43 with diabetes mellitus) to 1133 healthy male controls.
  • Analyzed erectile dysfunction (ED) prevalence and severity across different age groups using logistic regression.

Main Results:

  • HD patients exhibited significantly higher prevalence and severity of ED across all age groups compared to controls.
  • Diabetes mellitus and advanced age were identified as significant risk factors for sexual dysfunction in HD patients.
  • ED was particularly prevalent in older HD patients with diabetes mellitus.

Conclusions:

  • Male renal failure patients on hemodialysis experience a higher burden of erectile dysfunction.
  • Diabetes and age are critical factors contributing to ED in the hemodialysis population.
  • Targeted interventions for ED in HD patients should consider age and diabetes status.

Related Concept Videos

Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.